$10B in bridge payments flow to farmers, but losses still outpace support (Successful Farming): The USDA has now distributed nearly $9.6 billion in Farmer Bridge Assistance payments to crop producers, as weak commodity prices and high input costs continue to squeeze farm margins. The program—designed as short-term relief—has approved close to 500,000 applications, with the largest share of funding going to major row crops. Corn alone received about $3.45 billion, followed by soybeans at $2.27 billion, with additional support spread across wheat, cotton, and rice.
Despite the scale of the payments, many farms are still struggling to stay profitable. Industry estimates suggest most row crop operations are operating at or below breakeven—even after federal support is factored in. The assistance is helping stabilize cash flow, but it is not fully offsetting the downturn driven by lower prices and rising costs for inputs like fertilizer and fuel.
Geographically, payments are concentrated in major production states, with Iowa, Texas, and Illinois receiving the largest totals so far. The program is intended to act as a financial bridge until updates to farm safety net programs—like ARC and PLC—take effect later this year. However, with input costs still elevated and additional payment details for specialty crops not yet finalized, pressure across the ag economy could persist, leaving the door open for further support discussions.
Supreme Court signals uncertainty in Roundup lawsuits, leaving Bayer’s liability in question (Bloomberg): Bayer’s effort to limit ongoing Roundup lawsuits ran into a mixed response at the U.S. Supreme Court this week, with justices divided over how much weight federal pesticide approvals should carry against state-level claims. The case focuses on whether EPA-approved labels for glyphosate products should shield the company from lawsuits alleging it failed to warn about cancer risks. Some justices appeared sympathetic to Bayer’s argument that a patchwork of state rulings could create inconsistent labeling requirements for farmers and ag retailers, while others questioned whether federal regulators should fully preempt claims if new health concerns arise.
The case stems from a Missouri lawsuit where a farmer or applicator claimed long-term exposure to Roundup contributed to non-Hodgkin lymphoma, leading to a jury award against Bayer. The company maintains that because the EPA has repeatedly concluded glyphosate is unlikely to cause cancer and has not required a warning label, it should not be held liable under state law. However, several justices raised concerns about limiting producers’ and applicators’ ability to seek damages if federal guidance does not reflect evolving science.
For farmers, the outcome could shape both the future availability and legal landscape around glyphosate-based herbicides. A ruling in Bayer’s favor could reduce legal pressure on manufacturers and help maintain the current regulatory framework. If the court sides against Bayer, it could keep litigation active and potentially lead to changes in labeling, risk communication, or even product availability over time. A final decision is expected later this year and will be closely watched across the ag sector.